Andra AP fonden Decreases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Andra AP fonden decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 29.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 11,300 shares of the medical equipment provider’s stock after selling 4,700 shares during the quarter. Andra AP fonden’s holdings in Intuitive Surgical were worth $5,898,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of ISRG. Bennett Selby Investments LP increased its position in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares in the last quarter. Onefund LLC boosted its position in Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after purchasing an additional 18 shares during the period. LVW Advisors LLC increased its holdings in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. raised its position in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 3.7% during the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now owns 3,282 shares of the company’s stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the transaction, the vice president now directly owns 473 shares of the company’s stock, valued at $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,579 shares of company stock valued at $7,756,844 over the last 90 days. 0.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. Raymond James increased their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Evercore ISI increased their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Truist Financial boosted their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Barclays raised their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Finally, Leerink Partners lifted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Get Our Latest Stock Analysis on ISRG

Intuitive Surgical Trading Down 3.8 %

Shares of ISRG opened at $518.26 on Friday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a market cap of $184.59 billion, a price-to-earnings ratio of 80.85, a PEG ratio of 5.85 and a beta of 1.43. The stock has a 50 day moving average of $571.36 and a 200-day moving average of $531.53.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.